• HRC2019
  • 6 - 9 Oct 2019, The ICC, Birmingham UK
08:30 - 12:15 Oral Abstracts (1) Hall 7
08:30 - 17:15 STARS Take Fainting to Heart: Syncope & PoTs Update Hall 8a
08:30 - 17:15 Paediatric Hall 8b
08:30 - 10:00 Master Class Devices (1) - Achieving Optimal CRT Hall 9
08:30 - 10:00 GUCH (1) - How Should We Treat Acute Arrhythmias In CHD Patients? Hall 10b
08:30 - 12:15 Arrhythmia Alliance Session Pacemaker and ICD therapy - past, present, and future Hall 11
10:45 - 12:15 Master Class Devices (2) - The Big Debate Hall 9
10:45 - 12:15 GUCH (2) - Difficult patients and difficult arrhythmias - how can we improve ablation success and reduce complications? Hall 10b
13:30 - 17:15 Young Investigators Competition Hall 7
13:30 - 17:15 AF Association Improving AF Outcomes in the Lab Hall 9
13:30 - 15:00 AICC (1) - Risk Stratification In The Cardiomyopathies Hall 11
13:30 - 15:00 Biosense Webster Treatment of Atrial Fibrillation: Are we any closer to curing AF? Hall 10b
15:00 - 15:45 Moderated Posters (1) Poster Area, Hall 3
15:45 - 17:15 AICC (2) - The Repolarisation Syndromes Hall 11
10:45 - 12:15 Bayer - Managing the Complex Cardiovascular Patient Interactive Area, Hall 3
12:30 - 13:15 The new SIGN guidelines on Arrhythmias in Coronary Heart Disease Interactive Area, Hall 3

Oral Abstracts (1) - Hall 7 - 08:30 - 12:15

Chair: Ms Holly Daw, Dr Nolan Stain London, UK, London, UK
08:30 NURSE LED PACING IS HERE: INNOVATION AND TRANSFORMATION Mr Kiran Patel Sutton Coldfield, UK
08:45 THE CLINICAL AND FINANCIAL IMPACT OF A NEW NURSE-LED SERVICE FOR INSERTION OF IMPLANTABLE LOOP RECORDERS AT UHL Ms Susanne Armstrong Leicester, UK
09:00 OPTIMISING THE MANAGEMENT OF POST-SURGICAL TEMPORARY PACING CARE. A REVIEW OF A NOVEL CARDIAC PHYSIOLOGIST LEAD PACING SERVICE Mr Daniel Meese Harefield, UK
09:15 6 MONTHS PROSPECTIVE AUDIT OF IMPLANTABLE LOOP RECORDERS - WHAT DOES THIS TELL US ABOUT DIAGNOSTIC YIELD ? Ms Susanne Armstrong Leicester, UK
09:30 DEVELOPMENT, IMPLEMENTATION AND AUDIT OF LOCALLY AGREED STANDARDS FOR PERMANENT PACEMAKER FOLLOW-UP Ms Emma Beaney Middlesbrough, UK
09:45 APPROPRIATE ILR PROGRAMMING IMPROVES DETECTION OF EVENTS AND REDUCES INAPPROPRIATE ALERTS. REDUCTION IN HOME MONITORING WORKLOAD FOR PHYSIOLOGISTS MADE POSSIBLE. Ms Carrie Little Swindon, UK
10:00 Break
10:45 - 12:15 Chair: Dr Larissa Fabritz Birmingham, UK
10:45 ATRIAL FIBRILLATION OPPORTUNITY GAP ANALYSIS TOOL TO AID ALLOCATION OF RESOURCES TO DETECT CASES AND PROTECT AGAINST COMPLICATIONS Dr Andrzei Orlowski London, UK
11:00 REFINING STROKE RISK STRATIFICATION IN LOW RISK PATIENTS WITH ATRIAL FIBRILLATION: DERIVATION OF THE ABCD SCORE FROM A NATIONWIDE MULTI-CENTER REGISTRY Dr Seung Yong Shin Birmingham, UK
11:15 IS SLEEP APNOEA UNRECOGNISED IN PATIENTS WITH ATRIAL FIBRILLATION?  Dr Caroline Broughton Stoke on Trent, UK
11:45 INCIDENCE OF LEFT ATRIAL APPENDAGE THROMBUS IN PATIENTS UNDERGOING AF ABLATION IN THE NOAC ERA: IS TOE NEEDED IN LOW RISK PATIENTS? Dr Mark Taylor Middlesbrough, UK
12:00 NON-PULMONARY VEIN TRIGGERS OF ATRIAL FIBRILLATION IN PATIENTS WITH COMPLETE PULMONARY VEIN ISOLATION Dr Min-young Kim London, UK

STARS Take Fainting to Heart: Syncope & PoTs Update 		STARS Take Fainting to Heart: Syncope & PoTs Update - Hall 8a - 08:30 - 17:15

Chair: Dr Robert Sheldon, Professor Rose-Anne Kenny Calgary, CA, Eire, IE
08:30 Plenary: Models of care for patients with syncope in the acute care sector Dr Giorgio Costantino
08:50 Outcomes of syncope patients Dr Monica Solbiati Milan, IT
09:05 Risk scores for syncope patients in the ED Professor Venkatesh Thiruganasambandamoorthy Ottawa, CA
09:25 Should we manage syncope patients better and less expensively by avoiding admission in majority of cases?’ Dr Neil Sulke Eastbourne UK
09:40 Ivabradine & Vasovagal Syncope Professor Richard Sutton Monte Carlo, MC
10:00 Break
10:45 Syncope & Frailty Professor Rose-Anne Kenny Eire, IE
11:00 Norepinephrine transport inhibitors and vasovagal syncope Dr Satish Raj Calgary, CA
11:20 Syncope and heart block: pacemaker versus implantable loop recorder Dr Satish Raj Calgary, CA
11:40 Vasovagal Syncope; multiple physiologie, multiple syndromes? Dr Boon Lim London, UK
12:15 Break
Chair: Professor Richard Sutton, Dr Robert Sheldon Monte Carlo, MC, Calgary, CA
13:30 What is new in the 2018 ESC guidelines for the diagnosis and management of syncope? Professor Rose-Anne Kenny Eire, IE
13:50 Definition and classification of syncopal and non-syncopal forms of transient loss of consciousness Professor Richard Sutton Monte Carlo, MC
14:05 The diagnostic criteria of history taking and initial evaluation Dr Boon Lim London, UK
14:25 Key messages and recommendations Dr Robert Sheldon Calgary, CA
14:40 ESC, ACC,AHA, HRS: what are the differences and are they important? Professor A John Camm London, UK
15:00 Break
15:45 Update on research and guidance in POTS Professor Blair Grubb Toledo, USA
16:00 How can I diagnose PoTS - history, tests and what they all mean Dr Nicholas Gall London, UK
16:15 A therapeutic approach Dr Nicholas Gall London, UK
16:30 Autoantibodies: quirky finding or future therapy? Professor Artur Fedorowski Lund, SE
16:45 Hypermobility and mast cell activation disorder Dr Nicholas Gall London, UK
17:00 How can a neurologist help - neuropathy, MS, migraines, vertigo, sleep Dr Paul Cooper Manchester, UK
17:15 Close

Paediatric - Hall 8b - 08:30 - 17:15

Chair: Dr Joseph de Giovanni, Dr Maria Ilina Birmingham, UK, Glasgow, UK
08:30 Causes of sudden death, risk factors and epidemiology in children Dr Leonie Wong London, UK
09:00 Genetics of sudden death screening, techniques, timing, yield rate and recommendations (LQT, CPVT, Brugada, ARVC, HCM, LVNC, DCM) Professor Dhavendra Kumar Cardiff UK
09:30 Screening for Long QT: who should be screened, how should be screened, when and how often? Dr Jan Till London, UK
09:45 Screening for Brugada: who should be screened, how should be screened, when and how often? Dr Karen McLeod Glasgow, UK
10:00 Break
Chair: Dr Graham Stuart, Professor Orhan Uzun Bristol, UK, Cardiff, UK
10:45 Screening recommendations for cardiomyopathies ARVC, HCM, LVNC, DCM: who should be screened, how should be screened, when and how often? Dr Juan Kaski London, UK
11:30 Management of inherited sudden death syndromes: Current and emerging therapies Dr Neil Seller
11:45 Oral abstract presentations
11:45 "PERMANENT PACEMAKER IMPLANTATION AFTER PAEDIATRIC HEART TRANSPLANTATION: RISK FACTORS, INDICATIONS AND OUTCOMES " Mr Adil Mahmood London, UK
12:00 "AETIOLOGY AND OUTCOMES OF PAEDIATRIC OUT-OF-HOSPITAL CARDIAC ARREST SURVIVORS " Mr Atif Siddiqui London, UK
12:15 "PREVALENCE OF LEFT AXIS DEVIATION IN CHILDREN WITH LONG QT SYNDROME " Ms Sabie Rainton London, UK
12:30 Break
Chair: Dr Jasveer Mangat, Dr Karen McLeod London UK, Glasgow, UK
13:30 Diagnostic use and interpretation of Holter, event recorders, alivecor and implantable loops: red flags and clinical scenarios Dr Jasveer Mangat London UK
14:00 Utility of treadmill exercise test in the investigation of sudden death syndromes: what are the red flags for HCM, ARCV, CPVT, LQT and Brugada? Dr Shankar Sadagopan Southampton, UK
14:30 HUTT test responses, assessment of autonomic function, heart rate variability, QT variability: scientific and clinical correlations Dr Dom Hares Leeds, UK
15:00 Break
Chair: Professor Orhan Uzun, Dr Vinay Bhole Cardiff, UK, Birmingham, UK
15:45 Unknown ECG tracings and their interpretation in the EP lab: basic principles of EP for non specialists. Dr Joseph de Giovanni Birmingham, UK
16:00 Device primers for non specialist: pacemaker and ICD types, optimum programming principles in newborns, small children and adolescents Professor Eric Rosenthal London, UK
16:30 Pacemaker and ICD related symptoms, clinical problems, unknown tracings, their interpretation and practical solutions. Dr Graham Stuart Bristol, UK
17:15 Close

Master Class Devices (1) - Achieving Optimal CRT - Hall 9 - 08:30 - 10:00

Chair: Dr Ashish Patwala, Professor Richard Schilling Stoke on Trent, UK, London, UK
08:30 The CRT implanters perspective Dr Philip Moore Watford, UK
09:00 The Physiologist in CRT Clinic perspective Mr Stuart Allen Manchester, UK
09:30 The HF cardiologist perspective Dr Colin Cunnington Manchester, UK
10:00 Close

GUCH (1) - How Should We Treat Acute Arrhythmias In CHD Patients? - Hall 10b - 08:30 - 10:00

Chair: Dr Martin Lowe London, UK
08:30 Which patient, which drug, and is there an alternative to amiodarone? Dr Joseph de Bono Birmingham, UK
09:00 Which patients needs ablation, and how do we get the best result? Dr Arthur Yue Southampton, UK
09:30 Which patient needs a device, and which one is best? Dr Vivienne Ezzat London, UK
10:00 Close

Arrhythmia Alliance Session Pacemaker and ICD therapy - past, present, and future Arrhythmia Alliance Session Pacemaker and ICD therapy - past, present, and future - Hall 11 - 08:30 - 12:15

08:30 - 10:00 Chair: Dr Francis Murgatroyd, Dr Paul Foley London, UK, Swindon, UK
08:30 The history of pacemakers - 60 years and going strong Professor Richard Sutton Monte Carlo, MC
08:50 His bundle pacing: theory, and tips and tricks for His bundle lead implantation Dr Zachary Whinnett London, UK
09:10 His bundle pacing as a treatment for patients with heart failure Dr Daniel Keene
09:30 The global experience with Bridge- SVC occlusion balloon Dr Samer Hakmi Hamburg, Germany
09:50 Panel discussion/questions
10:00 Break
Chair: Professor Richard Sutton, Dr Zachary Whinnett Monte Carlo, MC, London, UK
10:45 State of the Art - Pacemakers and ICDs Dr Francis Murgatroyd London, UK
11:10 The future of subcutaneous ICDs Professor Pier Lambiase London, UK
11:35 What will device therapy look like in another 60 years? Dr Edward Rowland London, UK
12:00 Panel discussion/questions
12:15 Close

Master Class Devices (2) - The Big Debate - Hall 9 - 10:45 - 12:15

Chair: Dr Adrian Morley-Davies Stoke on Trent, UK
10:45 All CIEDS are MRI safe-Pro Dr Charlotte Manistry London, UK
10:45 All CIEDS are MRI safe-Ant Dr Kim Rajappan Oxford, UK
11:30 All VVI patients should receive a leadless pacemaker-Pro Dr Amir Zaidi Manchester, UK
11:30 All VVI patients should receive a leadless pacemaker-Ant Dr Mark Mason Uxbridge, UK
12:15 Close

GUCH (2) - Difficult patients and difficult arrhythmias - how can we improve ablation success and reduce complications? - Hall 10b - 10:45 - 12:15

Chair: Dr Martin Lowe London, UK
10:45 Ebstein's and accessory pathways, and how I avoid the AV node Dr Sabine Ernst London, UK
11:15 Fontan and atrial tachycardia; AP, lateraltunnel and TCPC Dr Ashley Nisbet Bristol, UK
11:45 Right ventricular outflow tract scar and ventricular tachycardia Dr Arthur Yue Southampton, UK
12:15 Close

Young Investigators Competition - Hall 7 - 13:30 - 17:15

Chair: Professor Andre Ng Leicester UK
Judge Prof Aldo Rinaldi London, UK
Judge Dr Arthur Yue Southampton, UK
Judge Prof Francisco Leyva Birmingham, UK
13:30 THE FUTURE OF S-ICD SENSING: ‘IMPROVE’ SIGNIFICANTLY INCREASES R:T RATIO AND GENERATES UNIVERSAL DEVICE ELIGIBILITY WITHOUT IMPAIRING VF DETECTION Dr Ben Wiles Romsey, UK
14:00 QT INTERVAL AND EXERCISE QT DYNAMICS FROM 58,852 INDIVIDUALS IN UK BIOBANK PREDICT VENTRICULAR ARRHYTHMIAS AND HEART FAILURE Dr Stefan van Duijvenboden London, UK
14:30 MEAN ENTROPY PREDICTS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY USING CARDIAC MAGNETIC RESONANCE TEXTURE ANALYSIS OF SCAR HETEROGENEITY Dr Justin Gould London, UK
Break
15:45 A MULTI-CENTRED EVALUATION OF HIGH POWERED ABLATION GUIDED BY ABLATION INDEX: ESTABLISHING ABLATION TARGETS FOR PULMONARY VEIN ISOLATION. Dr Gurpreet Dhillon London, UK
16:15 CRYOABLATION FOR PERSISTENT AND LONG STANDING PERSISTENT ATRIAL FIBRILLATION: RESULTS FROM A MULTICENTRE EUROPEAN REGISTRY Dr Vinit Sawhney London, UK
16:45 SAFETY AND EFFICACY OF WIRELESS LV ENDOCARDIAL PACING; A MULTICENTRE INTERNATIONAL STUDY EXAMINING REAL WORLD USE OF THE WISE CRT PACING SYSTEM Dr Ben Sieniewicz London, UK

AF Association Improving AF Outcomes in the Lab 		AF Association Improving AF Outcomes in the Lab - Hall 9 - 13:30 - 17:15

Chair: Professor Richard Schilling London, UK
13:30 AF ablation on uninterrupted NOAC therapy: the new standard of care? Dr Richard Balasubramaniam Bournemouth, UK
14:00 The use of Ultra High Density Mapping in treating complex atrial arrhythmias Dr Steve Murray Newcastle Upon Tyne, UK
14:30 What next after STAR AF II: recent randomized Trials of Adjunctive Ablation Strategies for Persistent Atrial Fibrillation Dr Mark Gallagher London, UK
15:00 Break
15:45 Panoramic Mapping for AF: Toys or Useful Tools? Dr Ross Hunter London, UK
16:15 Endocardial Voltage substrate mapping for AF: When, how and why? Dr Steve Williams London, UK
16:45 Hot and Cold Balloons for AF Ablation: their role and limitations Dr Dhiraj Gupta Liverpool UK
17:15 Close

AICC (1) - Risk Stratification In The Cardiomyopathies			AICC (1) - Risk Stratification In The Cardiomyopathies - Hall 11 - 13:30 - 15:00

Chair: Dr Amanda Varnava, Dr Sam Mohiddin London, UK, London, UK
13:30 The US vs ESC scores in HCM Dr Kevin Leong London, UK
13:50 Current risk stratification in ARVC Dr Stephen Page Leeds, UK
14:10 Can genotyping help risk stratification in DCM? Dr Tessa Homfray London, UK
14:30 DCM: who needs an ICD? Professor Pier Lambiase London, UK
14:50 Session discussion
15:00 Close

Biosense Webster Treatment of Atrial Fibrillation: Are we any closer to curing AF?  		Biosense Webster Treatment of Atrial Fibrillation: Are we any closer to curing AF? - Hall 10b - 13:30 - 15:00

Chair: Dr Ashley Nisbet Bristol, UK
13:30 Biophysics of RF ablation of new ablation modalities to optimize energy delivery in AF ablation Dr Massimo Grimaldi
14:15 Software for analysis of Persistent AF activation: Mapping Workflows and Ablation Strategy Dr Ross Hunter, . Sherry Honerbahksh London, UK
15:00 Close

Moderated Posters (1) - Poster Area, Hall 3 - 15:00 - 15:45

Chair: Dr Ashley Nisbet, Professor Prapa Kanagaratnam Bristol, UK, London, UK

AICC (2) - The Repolarisation Syndromes		AICC (2) - The Repolarisation Syndromes - Hall 11 - 15:45 - 17:15

Chair: Professor Elijah Behr , Dr Jan Till London, UK, London, UK
15:45 The clinical spectrum of the early repolarisation syndrome Dr Andrew Grace Cambridge, UK
16:05 The genetic basis of idiopathic VF Dr Greg Mellor Cambridge, UK
16:25 The role for family screening in idiopathic VF Professor Pier Lambiase London, UK
16:45 The role of medical therapy in idiopathic VF Professor Elijah Behr London, UK
17:00 Ablation in idiopathic VF Dr Sharad Agarwal Cambridge UK
17:15 Close

Bayer - Managing the Complex Cardiovascular Patient Bayer - Managing the Complex Cardiovascular Patient - Interactive Area, Hall 3 - 10:45 - 12:15

10:45 - 12:15 Chair: Professor A John Camm London, UK
10:45 Defining the complex cardiovascular patient Professor A John Camm London, UK
11:00 Novel management of your patients with coronary artery disease Dr Derek Connolly Birmingham, UK
11:30 Assessment and treatment of further events: AF and ACS Dr Azfar Zaman
11:50 Beyond the clinic - long term management of stroke prevention and vascular protection in primary care Dr Matthew Fay Bradford UK
12:10 Summary & Close Professor A John Camm London, UK

The new SIGN guidelines on Arrhythmias in Coronary Heart Disease - Interactive Area, Hall 3 - 12:30 - 13:15

12:30 Introduction: the scope of the SIGN guidelines on Coronary Heart Disease Dr Derek T Connelly Glasgow, UK
12:40 Acute treatment of Arrhythmias: What's new? Dr Derek T Connelly Glasgow, UK
12:50 Long-term treatment of Arrhythmias: What's new? Dr Derek T Connelly Glasgow, UK
13:00 What's in the Guidelines for Patients and Carers? Dr Derek T Connelly Glasgow, UK

Sign up to receive the latest updates